Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Engineered Factor IX with Augmented Clotting Activities in a Hemophilia B Mouse Model.

Chia-Ni Lin, Chung-Yang Kao, Chia-Lun Hong, Peiqing Ye, Carol H. Miao, PhD, Nobuko Hamaguchi, Hua-Lin Wu, Guey-Yueh Shi, Yung-Li Yang, I-Shing Yu, Mi-Hua Tao, Cheng-Chieh Fang, Yi-Lin Liu, Katherine A. High, MD, Shu-Wha Lin

Blood (2008) 112 (11): 2025.

https://doi.org/10.1182/blood.V112.11.2025.2025

Published: 2008

Journal Articles

Nonsense Suppression Approaches in Treating Hemophilia

Yi-Lin Liu, Paris Margaritis, Fayaz Khazi, Harre Downey, Stephan Kadauke, Nicole Hasbrouck, Josephine Sheedy, Ellen Welch, Marla Weetall, Katherine A. High, MD

Blood (2008) 112 (11): 512.

https://doi.org/10.1182/blood.V112.11.512.512

Published: 2008

Journal Articles

A Novel Deletion in the Fviii B-Domain That Reduces Transgene Size While Preserving FVIII Activity.

Yi-Lin Liu, MS, Hua Zhu, BS, Alexander Schlachterman, BA, Heesoon Chang, PhD, Rodney M. Camire, PhD, Katherine A. High, MD

Blood (2004) 104 (11): 3182.

https://doi.org/10.1182/blood.V104.11.3182.3182

Published: 2004

Journal Articles

In Vivo Evidence of Modulation of the Hemophilia Phenotype by the Factor V Leiden.

Alexander Schlachterman, Jianhua Liu, Yi-Lin Liu, Katherine High, MD, Valder Arruda, MD, PhD

Blood (2004) 104 (11): 693.

https://doi.org/10.1182/blood.V104.11.693.693

Published: 2004

Journal Articles

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene

Denise E. Sabatino, Elina Armstrong, Shyrie Edmonson, Yi-Lin Liu, Marc Pleimes, Joerg Schuettrumpf, Julie Fitzgerald, Roland W. Herzog, Valder R. Arruda, Katherine A. High

Blood (2004) 104 (9): 2767–2774.

https://doi.org/10.1182/blood-2004-03-1028

Published: 2004

Journal Articles

Induction of antigen-specific CD4 + T-cell anergy and deletion by in vivo viral gene transfer

Eric Dobrzynski, Federico Mingozzi, Yi-Lin Liu, Elisabeth Bendo, Ou Cao, Lixin Wang, Roland W. Herzog

Blood (2004) 104 (4): 969–977.

https://doi.org/10.1182/blood-2004-03-0847

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Engineered Factor IX with Augmented Clotting Activities in a Hemophilia B Mouse Model.

Nonsense Suppression Approaches in Treating Hemophilia

A Novel Deletion in the Fviii B-Domain That Reduces Transgene Size While Preserving FVIII Activity.

In Vivo Evidence of Modulation of the Hemophilia Phenotype by the Factor V Leiden.

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene

Induction of antigen-specific CD4 + T-cell anergy and deletion by in vivo viral gene transfer

Email alerts

ASH Publications

American Society of Hematology

Update search

Engineered Factor IX with Augmented Clotting Activities in a Hemophilia B Mouse Model.

Nonsense Suppression Approaches in Treating Hemophilia

A Novel Deletion in the Fviii B-Domain That Reduces Transgene Size While Preserving FVIII Activity.

In Vivo Evidence of Modulation of the Hemophilia Phenotype by the Factor V Leiden.

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene

Induction of antigen-specific CD4 + T-cell anergy and deletion by in vivo viral gene transfer

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only